Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bellardia trixago
- Development stage
- Discontinued
- Modality
- Small Molecules
- Administration
- Oral, Topical
01
Overview
Bellardia trixago is a hemiparasitic annual herb native to the Mediterranean region and currently classified in the family Orobanchaceae (formerly Scrophulariaceae)[4][7]. It has a history of use in traditional medicine for treating backache, menstrual problems, as an antipyretic, and for purported anti-inflammatory and antimicrobial effects[1][2][4]. Some sources also mention its use against human immunodeficiency virus and for ailments such as toothaches, headaches, coughs, and other inflammatory conditions[4][8]. The plant contains various bioactive compounds including essential oils (notably cembrene as the major component), flavonoids with antifungal activity, iridoid glucosides like geniposidic acid, and other secondary metabolites[3][4][6]. There is no evidence that Bellardia trixago or its extracts are approved pharmaceuticals; rather it is used in folk medicine or studied for potential bioactivity.
- Other names
- Bartsia trixago
02
Targets
Sucrase-IsomaltaseKRAS (Kirsten rat sarcoma viral oncogene homolog)VEGFC (VEGF-C)IGF-1R (Insulin-like growth factor 1 receptor)TYR (Tyrosinase)EGFR (Epidermal growth factor receptor)ButyrylcholinesteraseAcetylcholinesteraseAMY (Pancreatic alpha-amylase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Bellardia trixago.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bellardia trixago.